Delivery Order SPE2DB22D3501-SPE2DB23FVQ19
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,922.36 Firm Fixed Price Delivery Order covers the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award, valued at $2,712.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,510,655 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award is a delivery order worth $9,701.27 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,741.12 Firm Fixed Price Delivery Order is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,528.76 firm-fixed-price delivery order is for the supply of ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
- The federal contract award summarized here was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.37 firm fixed-price delivery order (SPE2DB20D1100|SPE2DB25FB1V3) is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to treat nausea and vomiting. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,491.43 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,610.82 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,791.65 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.09 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FVQ19Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,893.32 firm fixed-price delivery order is for 4,560,864,744 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 5/8/23 |